KNOW Bio

Executive Summary

KNOW Bio is a private life science incubator headquartered in Research Triangle Park, North Carolina, focused on advancing therapeutics based on nitric oxide and precision light therapy. Founded in 2015, the company operates by developing proprietary platform technologies and spinning out subsidiary companies dedicated to specific therapeutic areas, including cardiovascular, wound healing, and inflammatory diseases. By leveraging its extensive intellectual property portfolio, KNOW Bio aims to redefine standards of care across multiple indications. Although the company remains in early stages with limited public disclosures, its incubator model allows for diversified risk and multiple shots on goal. The upcoming period is expected to see progress in platform validation and potential formation of new subsidiaries or partnerships, which could unlock value for investors and stakeholders.

Upcoming Catalysts (preview)

• Q3 2026Announcement of a new subsidiary targeting a major indication (e.g., chronic wounds or cardiovascular disease)50% success
• H2 2026Partnership or licensing deal for nitric oxide platform with a pharmaceutical or medtech company40% success
• 2027Initiation of a Phase 1 clinical trial for a lead precision light therapy candidate30% success